(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.79%) $83.19
(-1.16%) $1.619
(-0.05%) $2 346.10
(-0.22%) $27.48
(0.24%) $924.30
(-0.10%) $0.934
(-0.05%) $11.02
(-0.16%) $0.799
(0.00%) $92.17
-41.94% US12542Q70 0.168
Live Chart Being Loaded With Signals
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics...
Stats | |
---|---|
本日の出来高 | 18.26M |
平均出来高 | 1.27M |
時価総額 | 1.14M |
EPS | US12542Q700 ( 2024-03-05 ) |
次の収益日 | ( US12542Q70-0.930 ) 2024-05-14 |
Last Dividend | US12542Q700 ( N/A ) |
Next Dividend | US12542Q700 ( N/A ) |
P/E | -0.0100 |
ATR14 | US12542Q700.00100 (0.59%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-02 | Mccormick Michael Kendrick | Buy | 20 836 | Nonstatutory Stock Option (right to buy) |
2024-01-02 | Mcdonald David | Buy | 11 365 | Nonstatutory Stock Option (right to buy) |
2024-01-02 | Feldshon Archelle Georgiou | Buy | 11 365 | Nonstatutory Stock Option (right to buy) |
2023-11-01 | Mcdonald David | Buy | 0 | |
2023-11-01 | Feldshon Archelle Georgiou | Buy | 0 |
INSIDER POWER |
---|
97.91 |
Last 90 transactions |
Buy: 3 285 386 | Sell: 12 287 |
ボリューム 相関
Nuwellis, Inc. 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Nuwellis, Inc. 相関 - 通貨/商品
Nuwellis, Inc. 財務諸表
Annual | 2023 |
収益: | US12542Q708.86M |
総利益: | US12542Q704.98M (56.22 %) |
EPS: | US12542Q70-10.29 |
FY | 2023 |
収益: | US12542Q708.86M |
総利益: | US12542Q704.98M (56.22 %) |
EPS: | US12542Q70-10.29 |
FY | 2022 |
収益: | US12542Q708.54M |
総利益: | US12542Q704.76M (55.66 %) |
EPS: | US12542Q70-83.48 |
FY | 2021 |
収益: | US12542Q707.92M |
総利益: | US12542Q704.49M (56.70 %) |
EPS: | US12542Q70-285.73 |
Financial Reports:
No articles found.
Nuwellis, Inc.
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。